Cardiac Surgery Market Size, Share, and Trends Analysis | Europe | 2024-2030 | MedSuite | Includes: Tissue Heart Valves, Mechanical Heart Valves, and 20 more

  • Year: 2024
  • Scope: 10 Years
  • Region: Europe
  • Pages: 784
  • Published Date: 01/04/2024
  • Type: MedSuite

Product Description

Overall, the European cardiac surgery market was valued at €2.9 billion in 2023. This is expected to increase over the forecast period at a CAGR of 3.4% to reach nearly €3.7 billion.

Throughout this medical market research, we analyzed over 40 cardiac surgery companies in the European market, and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

European Cardiac Surgery Market Insights

european cardiac surgery market

Cardiac surgery contends with emerging treatment alternatives, particularly the increasing prevalence of percutaneous coronary interventions (PCIs) and other interventional cardiology techniques, representing significant competition in the procedural landscape for the cardiac surgery market.

In Europe, there is a notable upward trend in the percentage of the aging population. This demographic, facing worsening cardiac conditions, is more inclined to require cardiac surgery. Consequently, the expanding patient base within this demographic is anticipated to drive growth in a majority of the markets analyzed in this report.

European Cardiac Surgery Market Share Analysis

european cardiac surgery marketIn 2023, Edwards Lifesciences emerged as the primary player in the cardiac surgery market, largely attributed to its dominance in the Transcatheter Heart Valve Replacement (THVR) segment. The cornerstone of Edwards Lifesciences’ THVR offerings includes the SAPIEN 3 ULTRA®, SAPIEN 3®, and SAPIEN XT®. The company also exhibits a robust presence in the tissue heart valve and annuloplasty segments.

Securing the second position in the cardiac surgery market for 2023, Abbott made significant strides following its acquisition of St. Jude Medical. This acquisition encompassed valuable product lines, particularly in the structural heart portfolio. Abbott solidified its standing with a notable presence in the transcatheter mitral valve repair market.

Taking the third spot among competitors in the cardiac surgery market in 2023, Medtronic’s strength emanates from its position in the THVR segment. The CoreValve Evolut R® Transcatheter Aortic Valve Replacement product played a pivotal role in consolidating Medtronic’s market position.

Market Segmentation Summary

  • Tissue Heart Valve Market – Includes:
    • Stented Tissue Heart Valves, Stentless Heart Tissue Valves, and Sutureless/Rapid Deployment Tissue Heart Valves.
  • Mechanical Heart Valve Market 
  • Annuloplasty Repair Device Market 
  • Transcatheter Mitral Valve Repair Market
  • Transcatheter Heart Valve Replacement Market – Includes:
    • Transcatheter Aortic Valve Replacement Market, Transcatheter Pulmonary Valve Replacement Market, and Transcatheter Mitral Valve Replacement Market.
  • Cerebral Embolic Protection Device Market
  • Balloon Valvuloplasty Market – Includes:
    • Aortic Balloon Valvuloplasty Market, Mitral Balloon Valvuloplasty Market, Pulmonary Balloon Valvuloplasty Market.
  • On-Pump Coronary Artery Bypass Device Market – Includes:
    • ONCAB Disposables Market, and Perfusion System Market.
  • Off-Pump Coronary Artery Bypass Device Market – Includes:
    • Stabilizer Market, and Positioner Market.
  • Autotransfusion Device Market – Includes:
    • Autotransfusion Machine Market, and Autotransfusion Disposables Market.
  • Endoscopic Vessel Harvesting Device Market
  • Anastomosis Assist Device Market 
  • Transmyocardial Revascularization Device Market – Includes:
    • Single-Use Fiber-Optic Handpiece Market, and Transmyocardial Revascularization Laser Console Market.
  • Ventricular Assist Device Market – Includes:
    • Percutaneous VAD Market, and Implantable VAD Market.
  • Intra-Aortic Balloon Device Market – Includes:
    • IAB Catheter Market, and IABP Console Market.
  • Artificial Heart Device Market
  • Patent Foramen Ovale Closure Device Market
  • Patent Ductus Arteriosus Closure Device Market
  • Atrial & Ventricular Septal Defect Closure Device Market – Includes:
    • Atrial Septal Defect Closure Market, and Ventricular Septal Defect Closure Device Market.
  • Left Atrial Appendage Closure Device Market – Includes:
    • Endocardial Market, Epicardial Clip Market, and Epicardial Suture Market.
  • Preshaped Guidewire Market
  • Extracorporeal Membrane Oxygenation Market – Includes:
    • ECMO Disposables Market, and ECMO Machine Market.

Research Scope Summary

Report AttributeDetails
RegionsEurope (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and the U.K.)
Base Year2023
Forecast2024-2030
Historical Data2020-2023
Quantitative CoverageMarket Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative CoverageCOVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data SourcesPrimary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE of CONTENTS
List of Figures
List of Charts
executive summary
European Cardiac Surgery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedures Included
Markets Included
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
impact of covid-19 on THE European Cardiac surgery Market
2.1 Introduction
2.2 Country Profile
2.3 Analysis By Market Segment
2.3.1 Worst Case Scenario
2.3.2 Base Case Scenario
2.3.3 Best Case Scenario
Disease Overview
3.1 Basic Anatomy
3.2 Disease Treatments & Diagnostics
3.2.1 Coronary Artery Disease
3.2.2 Myocardial Infarction
3.2.3 Angina Pectoris
3.2.4 Heart Valve Disease
3.2.5 Congestive Heart Failure
3.2.6 Aortic Stenosis
3.2.7 Degenerative/Functional Mitral Regurgitation
3.3 Patient Demographics
3.3.1 General Statistics
3.3.2 Coronary Artery Disease
3.3.3 Myocardial Infarction
3.3.4 Angina Pectoris
3.3.5 Heart Valve Disease
3.3.6 Congestive Heart Failure
Product Assessment
4.1 Introduction
4.2 Product Portfolios
4.2.1 Tissue Heart Valve Devices
4.2.2 Mechanical Heart Valve Devices
4.2.3 Annuloplasty Repair Devices
4.2.4 Transcatheter Mitral Valve Repair Devices
4.2.5 Transcatheter Heart Valve Replacement Devices
4.2.6 Cerebral Embolic Protection Devices
4.2.7 Balloon Valvuloplasty Devices
4.2.8 On-Pump Coronary Artery Bypass Devices
4.2.9 Off-Pump Coronary Artery Bypass Devices
4.2.10 Autotransfusion Devices
4.2.11 Endoscopic Vessel Harvesting Devices
4.2.12 Anastomosis Assist Devices
4.2.13 Transmyocardial Revascularization Devices
4.2.14 Ventricular Assist Devices
4.2.15 Intra-Aortic Balloon Pump Devices
4.2.16 Artificial Heart Devices
4.2.17 Patent Foramen Ovale Closure Devices
4.2.18 Patent Ductus Arteriosus Closure Devices
4.2.19 Atrial & Ventricular Septal Defect Closure Devices
4.2.20 Left Atrial Appendage Closure Devices
4.2.21 Preshaped Guidewires
4.2.22 Extracorporeal Membrane Oxygenation
4.3 Regulatory Issues and Recalls
4.3.1 Tissue Heart Valve Market FDA Recalls
4.3.2 Mechanical Heart Valve Market FDA Recalls
4.3.3 Annuloplasty Repair Device Market FDA Recalls
4.3.4 Transcatheter Mitral Valve Repair Device Market FDA Recalls
4.3.5 Transcatheter Heart Valve Replacement Device Market FDA Recalls
4.3.6 On-Pump Coronary Artery Bypass Device Market FDA Recalls
4.3.7 Off-Pump Coronary Artery Bypass Device Market FDA Recalls
4.3.8 Autotransfusion Device Market FDA Recalls
4.3.9 Endoscopic Vessel Harvesting Device Market FDA Recalls
4.3.10 Anastomosis Assist Device Market FDA Recalls
4.3.11 Ventricular Assist Device Market FDA Recalls
4.3.12 Intra-Aortic Balloon Pump Market FDA Recalls
4.3.13 Artificial Heart Device Market FDA Recalls
4.3.14 Patent Foramen Ovale Closure Device Market FDA Recalls
4.3.15 Atrial & Ventricular Septal Defect Closure Device Market FDA Recalls
4.3.16 Preshaped Guidewires Market FDA Recalls
4.3.17 Extracorporeal Membrane Oxygenation FDA Recalls
4.4 Clinical Trials
4.4.1 Tissue Heart Valve Market Clinical Trials
4.4.2 Mechanical Heart Valve Market Clinical Trials
4.4.3 Annuloplasty Repair Device Market Clinical Trials
4.4.4 Transcatheter Mitral Valve Repair Device Market Clinical Trials
4.4.5 Transcatheter Heart Valve Replacement Device Market Clinical Trials
4.4.6 Cerebral Embolic Protection Device Market Clinical Trials
4.4.7 Balloon Valvuloplasty Market Clinical Trials
4.4.8 Endoscopic Vessel Harvesting Device Market Clinical Trials
4.4.9 Transmyocardial Revascularization Device Market Clinical Trials
4.4.10 Ventricular Assist Device Market Clinical Trials
4.4.11 Intra-Aortic Balloon Pump Market Clinical Trials
4.4.12 Artificial Heart Device Market Clinical Trials
4.4.13 Patent Foramen Ovale Closure Device Market Clinical Trials
4.4.14 Patent Ductus Arteriosus Closure Device Market Clinical Trials
4.4.15 Left Atrial Appendage Closure Device Market Clinical Trials
4.4.16 Extracorporeal Membrane Oxygenation Clinical Trials
European Cardiac Surgery Market Overview
5.1 Introduction
5.2 Currency Exchange Rate
5.3 Market Overview & Trend Analysis
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
5.6 Mergers and Acquisitions
5.7 Company Profiles
5.7.1 Abbott
5.7.2 Abiomed
5.7.3 Artivion
5.7.4 AtriCure
5.7.5 B. Braun
5.7.6 Boston Scientific
5.7.7 Edwards Lifesciences
5.7.8 Getinge
5.7.9 LivaNova
5.7.10 Medtronic
5.7.11 Terumo
5.8 SWOT Analysis
5.8.1 Abbott
5.8.2 Abiomed
5.8.3 Artivion
5.8.4 AtriCure
5.8.5 B. Braun
5.8.6 Boston Scientific
5.8.7 Edwards Lifesciences
5.8.8 Getinge
5.8.9 LivaNova
5.8.10 Medtronic
5.8.11 Terumo
Country Profiles
6.1 Introduction
6.1.1 Population
6.1.2 GDP Per Capita
6.1.3 Price Index
6.2 Germany
6.3 France
6.4 United Kingdom
6.5 Italy
6.6 Spain
6.7 Benelux
6.8 Scandinavia
6.9 Austria
6.10 Switzerland
6.11 Portugal
Procedure Numbers
7.1 Total Cardiac Procedures
7.2 Surgical Heart Valve Replacement Procedures
7.2.1 Tissue Heart Valve Procedures
7.2.1.1 Tissue Heart Valve Procedures by Valve Type
7.2.1.1.1 Aortic Tissue Heart Valve Procedures
7.2.1.1.2 Mitral Tissue Heart Valve Procedures
7.2.1.1.3 Tricuspid Tissue Heart Valve Procedures
7.2.1.1.4 Pulmonary Tissue Heart Valve Procedures
7.2.1.2 Tissue Heart Valve Procedures by Tissue Type
7.2.1.2.1 Xenograft Tissue Heart Valve Procedures
7.2.1.2.2 Allograft Tissue Heart Valve Procedures
7.2.1.3 Tissue Heart Valve Procedures by Device Type
7.2.1.3.1 Stented Tissue Heart Valve Procedures
7.2.1.3.2 Stentless Tissue Heart Valve Procedures
7.2.1.3.3 Sutureless/Rapid Deployment Tissue Heart Valve Procedures
7.2.2 Mechanical Heart Valve Procedures
7.2.2.1 Aortic Mechanical Heart Valve Procedures
7.2.2.2 Mitral Mechanical Heart Valve Procedures
7.2.2.3 Tricuspid Mechanical Heart Valve Procedures
7.2.2.4 Pulmonary Mechanical Heart Valve Procedures
7.3 Annuloplasty Repair Procedures
7.3.1.1 Mitral Annuloplasty Repair Procedures
7.3.1.2 Tricuspid Annuloplasty Repair Procedures
7.4 Transcatheter Mitral Valve Repair Procedures
7.5 Transcatheter Aortic Valve Replacement Procedures
7.5.1 TAVR Procedures by Approach
7.5.1.1 Transfemoral TAVR Procedures
7.5.1.2 Transapical TAVR Procedures
7.5.1.3 Other TAVR Procedures
7.5.2 TAVR Procedures by Patient Risk Class
7.5.3 TAVR Procedures by Embolic Protection
7.5.3.1 TAVR Procedures with Cerebral Embolic Protection
7.5.3.2 TAVR Procedures without Cerebral Embolic Protection
7.6 Transcatheter Pulmonary Valve Replacement Procedures
7.7 Transcatheter Mitral Valve Replacement Procedures
7.8 Balloon Valvuloplasty Procedures
7.8.1 Aortic Balloon Valvuloplasty Procedures
7.8.2 Mitral Balloon Valvuloplasty Procedures
7.8.3 Pulmonary Balloon Valvuloplasty Procedures
7.9 Coronary Artery Bypass Grafting Procedures
7.9.1 CABG Procedures by Support
7.9.1.1 OPCAB CABG Procedures
7.9.1.2 ONCAB CABG Procedures
7.9.1.3 Minimally Invasive CABG Procedures
7.9.2 CABG Vessel Harvesting Procedures by Type
7.9.2.1 Open Vessel Harvesting CABG Procedures
7.9.2.2 Endoscopic Vessel Harvesting CABG Procedures
7.9.3 CABG Procedures by Suture Type
7.9.3.1 Traditional Suture CABG Procedures
7.9.3.2 Anastomosis Assist Device CABG Procedures
7.10 Autotransfusion Procedures
7.10.1 Cardiovascular and Other Autotransfusion Procedures
7.10.2 Orthopedic Procedures
7.11 Ventricular Assist Device Procedures by Type
7.11.1 Percutaneous VAD by Heart Side
7.11.1.1 Left Heart pVAD Procedures
7.11.1.2 Right Heart pVAD Procedures
7.11.2 Implantable VADs by Indication
7.11.2.1 Destination Therapy Implantable VAD
7.11.2.2 Bridge-to-Transplant Implantable VAD
7.11.2.3 Bridge-to-Recovery Implantable VAD
7.12 Intra-Aortic Balloon Pump Procedures
7.13 Artificial Heart Procedures
7.14 Patent Foramen Ovale Closure Procedures
7.15 Patent Ductus Arteriosus Procedures
7.16 Atrial & Ventricular Septal Defect Closure Procedures
7.16.1 Atrial Septal Defect Closure Procedures
7.16.2 Ventricular Septal Defect Closure Procedures
7.17 Left Atrial Appendage Closure Device Procedures
7.17.1 Endocardial Closure Device Procedures
7.17.2 Epicardial Clip Procedures
7.17.3 Epicardial Suture Procedures
7.18 Transmyocardial Revascularization Procedures
7.19 Extracorporeal Membrane Oxygenation Procedures
7.19.1 Venoarterial ECMO Procedures
7.19.2 Venovenous ECMO Procedures
7.19.3 Arteriovenous ECMO Procedures
tissue heart valve Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Tissue Heart Valve Market
8.3.2 Stented Tisue Heart Valve Market
8.3.3 Stentless Tissue Heart Valve Market
8.3.4 Sutureless/Rapid Deployment Tissue Heart Valve Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
mechanical heart valve Market
9.1 Introduction
9.2 Market Analysis and Forecast
9.3 Drivers and Limiters
9.3.1 Market Drivers
9.3.2 Market Limiters
9.4 Competitive Market Share Analysis
Annuloplasty Repair Device Market
10.1 Introduction
10.2 Market Analysis and Forecast
10.3 Drivers and Limiters
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 Competitive Market Share Analysis
Transcatheter Mitral Valve Repair Market
11.1 Introduction
11.2 Market Analysis and Forecast
11.3 Drivers and Limiters
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 Competitive Market Share Analysis
Transcatheter Heart ValVe replacement Market
12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
12.3.1 Total Transcatheter Heart Valve Replacement Market
12.3.2 Transcatheter Aortic Valve Replacement Market
12.3.3 Transcatheter Pulmonary Valve Replacement Market
12.3.4 Transcatheter Mitral Valve Replacement Market
12.4 Drivers and Limiters
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 Competitive Market Share Analysis
Cerebral Embolic Protection Device Market
13.1 Introduction
13.2 Market Analysis and Forecast
13.3 Drivers and Limiters
13.3.1 Market Drivers
13.3.2 Market Limiters
13.4 Competitive Market Share Analysis
Balloon Valvuloplasty Market
14.1 Introduction
14.2 Market Overview
14.3 Market Analysis and Forecast
14.3.1 Total Balloon Valvuloplasty Market
14.3.2 Aortic Balloon Valvuloplasty Market
14.3.3 Mitral Balloon Valvuloplasty Market
14.3.4 Pulmonary Balloon Valvuloplasty Market
14.4 Drivers and Limiters
14.4.1 Market Drivers
14.4.2 Market Limiters
14.5 Competitive Market Share Analysis
On-Pump Coronary Artery Bypass Device Market
15.1 Introduction
15.2 Market Overview
15.3 Market Analysis and Forecast
15.3.1 ONCAB Disposables Market
15.3.2 Perfusion System Market
15.4 Drivers and Limiters
15.4.1 Market Drivers
15.4.2 Market Limiters
15.5 Competitive Market Share Analysis
Off-Pump Coronary Artery Bypass Device Market
16.1 Introduction
16.2 Market Overview
16.3 Market Analysis and Forecast
16.3.1 Total OPCAB Market
16.3.2 Stabilizer Device Market
16.3.3 Positioner Market
16.4 Drivers and Limiters
16.4.1 Market Drivers
16.4.2 Market Limiters
16.5 Competitive Market Share Analysis
Autotransfusion Device Market
17.1 Introduction
17.2 Market Overview
17.3 Market Analysis and Forecast
17.3.1 Autotransfusion Machine Market
17.3.2 Autotransfusion Disposables Market
17.4 Drivers and Limiters
17.4.1 Market Drivers
17.4.2 Market Limiters
17.5 Competitive Market Share Analysis
Endoscopic Vessel Harvesting Device Market
18.1 Introduction
18.2 Market Analysis and Forecast
18.3 Drivers and Limiters
18.3.1 Market Drivers
18.3.2 Market Limiters
18.4 Competitive Market Share Analysis
Anastomosis Assist Device Market
19.1 Introduction
19.2 Market Analysis and Forecast
19.3 Drivers and Limiters
19.3.1 Market Drivers
19.3.2 Market Limiters
19.4 Competitive Market Share Analysis
Transmyocardial Revascularization Device Market
20.1 Introduction
20.2 Market Overview
20.3 Market Analysis and Forecast
20.3.1 Single-Use Fiber-Optic Handpiece Market
20.3.2 Transmyocardial Revascularization Laser Console Market
20.4 Drivers and Limiters
20.4.1 Market Drivers
20.4.2 Market Limiters
20.5 Competitive Market Share Analysis
Ventricular Assist Device Market
21.1 Introduction
21.2 Market Overview
21.3 Market Analysis and Forecast
21.3.1 Total Ventricular Assist Device Market
21.3.2 Total pVAD Market
21.3.2.1 Left Heart pVAD Market
21.3.2.2 Right Heart pVAD Market
21.3.3 Implantable VAD Market
21.4 Drivers and Limiters
21.4.1 Market Drivers
21.4.2 Market Limiters
21.5 Competitive Market Share Analysis
intra-aortic balloon device Market
22.1 Introduction
22.2 Market Overview
22.3 Market Analysis and Forecast
22.3.1 IAB Catheter Market
22.3.2 IABP Console Market
22.4 Drivers and Limiters
22.4.1 Market Drivers
22.4.2 Market Limiters
22.5 Competitive Market Share Analysis
Artificial Heart Device Market
23.1 Introduction
23.2 Market Analysis and Forecast
23.3 Drivers and Limiters
23.3.1 Market Drivers
23.3.2 Market Limiters
23.4 Competitive Market Share Analysis
Patent Foramen Ovale Closure Device Market
24.1 Introduction
24.2 Market Analysis and Forecast
24.3 Drivers and Limiters
24.3.1 Market Drivers
24.3.2 Market Limiters
24.4 Competitive Market Share Analysis
Patent Ductus Arteriosus Closure Device Market
25.1 Introduction
25.2 Market Analysis and Forecast
25.3 Drivers and Limiters
25.3.1 Market Drivers
25.3.2 Market Limiters
25.4 Competitive Market Share Analysis
Atrial & Ventricular Septal Defect Closure Device Market
26.1 Introduction
26.2 Market Overview
26.3 Market Analysis and Forecast
26.3.1 Total Atrial & Ventricular Septal Defect Closure Device Market
26.3.2 Atrial Septal Defect Closure Device Market
26.3.3 Ventricular Septal Defect Closure Device Market
26.4 Drivers and Limiters
26.4.1 Market Drivers
26.4.2 Market Limiters
26.5 Competitive Market Share Analysis
Left Atrial Appendage Closure Device Market
27.1 Introduction
27.2 Market Overview
27.3 Market Analysis and Forecast
27.3.1 Total Left Atrial Appendage Closure Device Market
27.3.2 Endocardial Market
27.3.3 Epicardial Clip Market
27.3.4 Epicardial Suture Market
27.4 Drivers and Limiters
27.4.1 Market Drivers
27.4.2 Market Limiters
27.5 Competitive Market Share Analysis
Preshaped Guidewire Market
28.1 Introduction
28.2 Market Analysis and Forecast
28.3 Drivers and Limiters
28.3.1 Market Drivers
28.3.2 Market Limiters
28.4 Competitive Market Share Analysis
Extracorporeal Membrane Oxygenation Market
29.1 Introduction
29.2 Market Overview
29.3 Market Analysis and Forecast
29.3.1 ECMO Disposables Market
29.3.2 ECMO Machine Market
29.4 Drivers and Limiters
29.4.1 Market Drivers
29.4.2 Market Limiters
29.5 Competitive Market Share Analysis
Abbreviations
·         Abbott·         JenaValve Technologies
·         Abiomed·         Keystone Heart
·         Artivion·         Labcor
·         AtriCure·         Lepu Medical
·         B. Braun·         Lifetech Scientific
·         Becton Dickinson·         LivaNova
·         Biosense Webster·         Med Europe
·         Biosensors·         MediValve
·         BioStable Science & Engineering, Inc.·         Medtronic
·         Boston Scientific·         Meril Life Science
·         Carag·         Nipro
·         Cardia·         Occlutech
·         Cardiac Dimensions·         PFM Medical
·         Cardio Medical·         Reliant Heart
·         Comed BV·         Simeks Medical
·         Corcym·         Spectrum Medical
·         Edwards Lifesciences·         SynCardia
·         EUROSETS·         Teleflex
·         Fresenius·         Terumo
·         Getinge·         Venus Medtech
·         Gore·         Vitalitec
·         Haemonetics·         Zeon Medical Inc.
·         Jarvik Heart
Chart 1‑1: European Cardiac Surgery Market by Segment, Europe, 2023
Chart 1‑2: European Cardiac Surgery Market Overview, Europe, 2023 & 2030
Chart 2‑1: Multi-Scenario Cardiac Surgery Market Forecast, Europe, 2020 – 2030 (€M)
Chart 5‑1: Cardiac Surgery Market by Segment, Europe, 2020 – 2030
Chart 5‑2: Leading Competitors, Cardiac Surgery Market, Europe, 2023
Chart 6‑1: Country Profile, Germany, 2023
Chart 6‑2: Country Profile, France, 2023
Chart 6‑3: Country Profile, United Kingdom, 2023
Chart 6‑4: Country Profile, Italy, 2023
Chart 6‑5: Country Profile, Spain, 2023
Chart 6‑6: Country Profile, Benelux, 2023
Chart 6‑7: Country Profile, Scandinavia, 2023
Chart 6‑8: Country Profile, Austria, 2023
Chart 6‑9: Country Profile, Switzerland, 2023
Chart 6‑10: Country Profile, Portugal, 2023
Chart 7‑1: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030
Chart 8‑1: Tissue Heart Valve Market by Segment, Europe, 2020 – 2030
Chart 8‑2: Leading Competitors, Tissue Heart Valve Market, Europe, 2023
Chart 9‑1: Mechanical Heart Valve Market, Europe, 2020 – 2030
Chart 9‑2: Leading Competitors, Mechanical Heart Valve Market, Europe, 2023
Chart 10‑1: Annuloplasty Repair Device Market, Europe, 2020 – 2030
Chart 10‑2: Leading Competitors, Annuloplasty Repair Device Market, Europe, 2023
Chart 11‑1: Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030
Chart 11‑2: Leading Competitors, Transcatheter Mitral Valve Repair Market, Europe, 2023
Chart 12‑1: Transcatheter Heart Valve Replacement Market by Segment, Europe, 2020 – 2030
Chart 12‑2: Leading Competitors, Transcatheter Heart Valve Replacement Market, Europe, 2023
Chart 13‑1: Cerebral Embolic Protection Device Market, Europe, 2020 – 2030
Chart 13‑2: Leading Competitors, Cerebral Embolic Protection Device Market, Europe, 2023
Chart 14‑1: Balloon Valvuloplasty Market by Segment, Europe, 2020 – 2030
Chart 14‑2: Leading Competitors, Balloon Valvuloplasty Market, Europe, 2023
Chart 15‑1: ONCAB Market by Segment, Europe, 2020 – 2030
Chart 15‑2: Leading Competitors, ONCAB Market, Europe, 2023
Chart 16‑1: OPCAB Market by Segment, Europe, 2020 – 2030
Chart 16‑2: Leading Competitors, OPCAB Market, Europe, 2023
Chart 17‑1: Autotransfusion Device Market by Segment, Europe, 2020 – 2030
Chart 17‑2: Leading Competitors, Autotransfusion Device Market, Europe, 2023
Chart 18‑1: Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030
Chart 18‑2: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Europe, 2023
Chart 19‑1: Anastomosis Assist Device Market, Europe, 2020 – 2030
Chart 19‑2: Leading Competitors, Anastomosis Assist Device Market, Europe, 2023
Chart 20‑1: Transmyocardial Revascularization Device Market by Segment, Europe, 2020 – 2030
Chart 21‑1: Ventricular Assist Device Market by Segment, Europe, 2020 – 2030
Chart 21‑2: Leading Competitors, Ventricular Assist Device Market, Europe, 2023
Chart 22‑1: Intra-Aortic Balloon Device Market by Segment, Europe, 2020 – 2030
Chart 22‑2: Leading Competitors, Intra-Aortic Balloon Device Market, Europe, 2023
Chart 23‑1: Artificial Heart Device Market, Europe, 2020 – 2030
Chart 23‑2: Leading Competitors, Artificial Heart Device Market, Europe, 2023
Chart 24‑1: Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030
Chart 24‑2: Leading Competitors, Patent Foramen Ovale Closure Device Market, Europe, 2023
Chart 25‑1: Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030
Chart 25‑2: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, Europe, 2023
Chart 26‑1: Atrial & Ventricular Septal Defect Closure Device Market by Segment, Europe, 2020 – 2030
Chart 26‑2: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2023
Chart 27‑1: Left Atrial Appendage Closure Device Market by Segment, Europe, 2020 – 2030
Chart 27‑2: Leading Competitors, Left Atrial Appendage Closure Device Market, Europe, 2023
Chart 28‑1: Preshaped Guidewire Market, Europe, 2020 – 2030
Chart 28‑2: Leading Competitors, Preshaped Guidewire Market, Europe, 2023
Chart 29‑1: ECMO Market by Segment, Europe, 2020 – 2030
Chart 29‑2: Leading Competitors, ECMO Market, Europe, 2023
Figure 1‑1: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (1 of 5)
Figure 1‑2: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (2 of 5)
Figure 1‑3: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (3 of 5)
Figure 1‑4: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (4 of 5)
Figure 1‑5: Cardiac Surgery Market Share Ranking by Segment, Europe, 2023 (5 of 5)
Figure 1‑6: Companies Researched in This Report
Figure 1‑7: Factors Impacting the Cardiac Market by Segment, Europe (1 of 5)
Figure 1‑8: Factors Impacting the Cardiac Market by Segment, Europe (2 of 5)
Figure 1‑9: Factors Impacting the Cardiac Market by Segment, Europe (3 of 5)
Figure 1‑10: Factors Impacting the Cardiac Market by Segment, Europe (4 of 5)
Figure 1‑11: Factors Impacting the Cardiac Market by Segment, Europe (5 of 5)
Figure 1‑12: Recent Events in the Cardiac Surgery Market, Europe, 2020 – 2023 (1 of 2)
Figure 1‑13: Recent Events in the Cardiac Surgery Market, Europe, 2020 – 2023
Figure 1‑14: Cardiac Surgery Procedures Covered, Europe (1 of 3)
Figure 1‑15: Cardiac Surgery Procedures Covered, Europe (2 of 3)
Figure 1‑16: Cardiac Surgery Procedures Covered, Europe (3 of 3)
Figure 1‑17: Cardiac Surgery Markets Covered, Europe (1 of 2)
Figure 1‑18: Cardiac Surgery Markets Covered, Europe (2 of 2)
Figure 1‑19: Key Report Updates
Figure 1‑20: Version History
Figure 2‑1: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3)
Figure 2‑2: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3)
Figure 2‑3: Cardiac Surgery Market by Segment, Worst Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3)
Figure 2‑4: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3)
Figure 2‑5: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3)
Figure 2‑6: Cardiac Surgery Market by Segment, Base Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3)
Figure 2‑7: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (1 of 3)
Figure 2‑8: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (2 of 3)
Figure 2‑9: Cardiac Surgery Market by Segment, Best Case Scenario, Europe, 2020 – 2030 (€M) (3 of 3)
Figure 4‑1: Tissue Heart Valve Devices by Company
Figure 4‑2: Mechanical Heart Valve Devices by Company
Figure 4‑3: Annuloplasty Repair Devices by Company
Figure 4‑4: Transcatheter Mitral Valve Repair Devices by Company
Figure 4‑5: Transcatheter Heart Valve Replacement Devices by Company
Figure 4‑6: Cerebral Embolic Protection Devices by Company
Figure 4‑7: Balloon Valvuloplasty Devices by Company
Figure 4‑8: On-Pump Coronary Artery Bypass Devices by Company (1 of 2)
Figure 4‑9: On-Pump Coronary Artery Bypass Devices by Company (2 of 2)
Figure 4‑10: Off-Pump Coronary Artery Bypass Devices by Company (1 of 2)
Figure 4‑11: Off-Pump Coronary Artery Bypass Devices by Company (2 of 2)
Figure 4‑12: Autotransfusion Devices by Company
Figure 4‑13: Endoscopic Vessel Harvesting Devices by Company
Figure 4‑14: Anastomosis Assist Devices by Company
Figure 4‑15: Transmyocardial Revascularization Devices by Company
Figure 4‑16: Ventricular Assist Devices by Company
Figure 4‑17: Intra-Aortic Balloon Pump Devices by Company
Figure 4‑18: Artificial Heart Replacement Devices by Company
Figure 4‑19: Patent Foramen Ovale Devices by Company
Figure 4‑20: Patent Ductus Arteriosus Closure Devices by Company
Figure 4‑21: Atrial & Ventricular Septal Defect Devices by Company
Figure 4‑22: Left Atrial Appendage Closure Devices by Company
Figure 4‑23: Preshaped Guidewires by Company
Figure 4‑24: Extracorporeal Membrane Oxygenation by Company (1 of 2)
Figure 4‑25: ECMO by Company (2 of 2)
Figure 4‑26: Class 2 Device Recall CryoValve SG Pulmonary Human Heart Valve
Figure 4‑27: Class 2 Device Recall PERCEVAL SUTURELESS HEART VALVE
Figure 4‑28: Class 2 Device Recall Hancock II T510 Bioprosthesis
Figure 4‑29: Class 2 Device Recall Mosaic 310 Bioprosthesis
Figure 4‑30: Class 2 Device Recall Cryovalve(R) SG Pulmonary Human Heart Valve
Figure 4‑31: Class 2 Device Recall, CryoLife
Figure 4‑32: Class 2 Device Recall Medtronic Open Pivot Aortic Valve Graft
Figure 4‑33: Class 2 Device Recall OnX Aortic Heart Valve
Figure 4‑34: Class 1 Device Recall, CryoLife
Figure 4‑35: Class 2 Device Recall Medtronic Simulus 850 Semi Rigid Ring/Band Accessory Kit
Figure 4‑36: Class 2 Device Recall Medtronic Simulus 750 Flexible Ring/Band Accessory Kit
Figure 4‑37: Class 2 Device Recall MitraClip" and TriClip" Delivery System(s)
Figure 4‑38: Class 2 Device Recall Abbott MitraClip XTR Clip Delivery System
Figure 4‑39: Class 2 Device Recall, Abbott
Figure 4‑40: Class 1 Device Recall Harmony Delivery Catheter System
Figure 4‑41: Class 1 Device Recall Lotus Edge Valve System
Figure 4‑42: Class 1 Device Recall Edwards Sapien 3 Ultra Delivery System
Figure 4‑43: Class 2 Device Recall Edwards SAPIEN 3 Transcatheter Heart Valve (THV)
Figure 4‑44: Class 2 Device Recall Quadroxi Pediatric
Figure 4‑45: Class 2 Device Recall QUADROXi Small Adult
Figure 4‑46: Class 2 Device Recall QUADROX i Neonatal
Figure 4‑47: Class 2 Device Recall QUADROXi Small Adult, BIOLINE Coated
Figure 4‑48: Class 2 Device Recall QUADROX iR
Figure 4‑49: Class 2 Device Recall Quadroxi Adult
Figure 4‑50: Class 2 Device Recall QUADROXi Small
Figure 4‑51: Class 2 Device Recall CAPIOX NX19
Figure 4‑52: Class 2 Device Recall CAPIOX RX15
Figure 4‑53: Class 2 Device Recall CAPIOX FX25
Figure 4‑54: Class 2 Device Recall Affinity Fusion Oxygenator
Figure 4‑55: Class 1 Device Recall LifeSPARC Controller
Figure 4‑56: Class 1 Device Recall Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface
Figure 4‑57: Class 2 Device Recall Capiox FX25 Advance Oxygenator
Figure 4‑58: Class 3 Device Recall ROTAFLOW Centrifugal Pump System
Figure 4‑59: Class 2 Device Recall ROTAFLOW Centrifugal Pump System
Figure 4‑60: Class 2 Device Recall Maquet/Getinge
Figure 4‑61: Class 3 Device Recall Smart Perfusion Pack
Figure 4‑62: Class 2 Device Recall Terumo Capiox NX19 Oxygenator
Figure 4‑63: Class 2 Device Recall
Figure 4‑64: Class 2 Device Recall ACROBAT V
Figure 4‑65: Class 2 Device Recall ACROBAT SUV
Figure 4‑66: Class 2 Device Recall ACROBATi
Figure 4‑67: Class 2 Device Recall CS Elite Fastpack
Figure 4‑68: Class 2 Device Recall CS Elite
Figure 4‑69: Class 2 Device Recall CS5/5 Fastpacks
Figure 4‑70: Class 2 Device Recall Cell Saver
Figure 4‑71: Class 2 Device Recall High Speed Cell Saver
Figure 4‑72: Class 2 Device Recall CSE Set
Figure 4‑73: Class 2 Device Recall CATSmart Autotransfusion
Figure 4‑74: Class 2 Device Recall CATSmart Vacuum Pump
Figure 4‑75: Class 2 Device Recall VASOVIEW HEMOPRO
Figure 4‑76: Class 2 Device Recall VASOVIEW HEMOPRO 2
Figure 4‑77: Class 2 Device Recall Cardica CPort xA PLUS Anastomosis System
Figure 4‑78: Class 2 Device Recall HeartWare" Ventricular Assist Device (HVAD") System
Figure 4‑79: Class 1 Device Recall Impella RP Flex with SmartAssist
Figure 4‑80: Class 1 Device Recall Impella LD
Figure 4‑81: Class 1 Device Recall Impella CP with SmartAssist
Figure 4‑82: Class 1 Device Recall Impella 5.0
Figure 4‑83: Class 1 Device Recall Impella 2.5
Figure 4‑84: Class 1 Device Recall Impella CP
Figure 4‑85: Class 2 Device Recall HeartWare
Figure 4‑86: Class 1 Device Recall Heartware HVAD
Figure 4‑87: Class 1 Device Recall HeartWare HVAD Pump Implant Kit
Figure 4‑88: Class 2 Device Recall HeartWare Ventricular Assist Device (HVAD) System
Figure 4‑89: Class 2 Device Recall HeartWare HVAD System
Figure 4‑90: Class 2 Device Recall HeartMate Touch Communication System
Figure 4‑91: Class 2 Device Recall TandemHeart Pump
Figure 4‑92: Class 1 Device Recall HVAD Pump Implant Kit
Figure 4‑93: Class 1 Device Recall HVAD Pump Outflow Graft
Figure 4‑94: Class 2 Device Recall HeartMate 3 Left Ventricular Assist System
Figure 4‑95: Class 2 Device Recall HeartMate Left Ventricular Assist System
Figure 4‑96: Class 2 Device Recall HeartMate Outflow Graft
Figure 4‑97: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
Figure 4‑98: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP)
Figure 4‑99: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑100: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑101: Class 2 Device Recall Cardiosave Rescue
Figure 4‑102: Class 2 Device Recall Safety Disk
Figure 4‑103: Class 2 Device Recall Cardiosave Rescue
Figure 4‑104: Class 2 Device Recall Cardiosave Hybrid
Figure 4‑105: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP)
Figure 4‑106: Class 1 Device Recall Arrow AutoCAT2
Figure 4‑107: Class 1 Device Recall Arrow AC3 Optimus
Figure 4‑108: Class 1 Device Recall AutoCAT IABP Series
Figure 4‑109: Class 1 Device Recall Arrow AutoCAT2
Figure 4‑110: Class 1 Device Recall AC3 Series IABP System
Figure 4‑111: Class 2 Device Recall SynCardia temporary Total Artificial Heart System
Figure 4‑112: Class 2 Device Recall Gore Cardioform Septal Occluder
Figure 4‑113: Class 2 Device Recall GORE CARDIOFORM SEPTAL OCCLUDER
Figure 4‑114: Class 2 Device Recall GORE CARDIOFORM ASD Occluder
Figure 4‑115: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
Figure 4‑116: Class 1 Device Recall Medtronic Confida Expandable Sheath
Figure 4‑117: Class 2 Device Recall HLS Set Advanced
Figure 4‑118: Class 2 Device Recall HLS Set Advanced
Figure 4‑119: Class 3 Device Recall Cardiac Assist
Figure 4‑120: Class 2 Device Recall TandemHeart Pump
Figure 4‑121: Class 1 Device Recall CentriMag Acute Circulatory Support System Motor
Figure 4‑122: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study (INVIVITY)
Figure 4‑123: Avalus European Registry - an Observational Study to Evaluate Safety and Efficacy in a Real World Population
Figure 4‑124: PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT)
Figure 4‑125: INSPIRIS RESILIA Valve in Pulmonary Position
Figure 4‑126: Trifecta and Epic ViV Detailed Insights into Management Strategies and Outcomes
Figure 4‑127: Trifecta™ Long Term Follow-Up (LTFU) Study
Figure 4‑128: Post Market Clinical Follow-Up Study in Patients Treated with the On-X Ascending Aortic Prosthesis (AAP) (ASCEND)
Figure 4‑129: Regent China Post-Market Clinical Follow-up Study
Figure 4‑130: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
Figure 4‑131: Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve
Figure 4‑132: HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve
Figure 4‑133: On-X Heart Valve - 17mm Aortic and 23mm Mitral
Figure 4‑134: HAART Annuloplasty Device Valve Repair Registry
Figure 4‑135: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study (ARB-PMCF)
Figure 4‑136: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation
Figure 4‑137: Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty with 3D Shaped Rings
Figure 4‑138: PRESERVE-MITRAL Post-Market Registry
Figure 4‑139: Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients with Mitral Valve Disease
Figure 4‑140: Valveclip® Transcatheter Mitral Valve Repair Study
Figure 4‑141: Caisson Transcatheter Mitral Valve Replacement (TMVR) (INTERLUDE)
Figure 4‑142: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR)
Figure 4‑143: Mi-thos® Transcatheter Mitral Valve Replacement (First-in-Man Study)
Figure 4‑144: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR)
Figure 4‑145: The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices
Figure 4‑146: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT)
Figure 4‑147: The PROTEMBO Trial
Figure 4‑148: PROTECT TAVI – Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Sentinel™ Device
Figure 4‑149: Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty
Figure 4‑150: Mini-invasive Balloon Aortic Valvuloplasty
Figure 4‑151: Comparison of Saphenous Vein Harvesting by Endoscopic Versus Open Conventional Methods
Figure 4‑152: CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study
Figure 4‑153: LVAD Conditioning for Cardiac Recovery
Figure 4‑154: EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Figure 4‑155: Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function
Figure 4‑156: The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study
Figure 4‑157: A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System
Figure 4‑158: Outcome of Patients Treated with IABP
Figure 4‑159: Intra-Aortic Balloon Pump in Extensive Myocardial Infarction with Persistent Ischemia
Figure 4‑160: Carmat Total Artificial Heart as a Bridge to Transplant in Patients with Advanced Heart Failure
Figure 4‑161: SynCardia 70cc TAH-t for Destination Therapy
Figure 4‑162: Syncardia 50cc TAH-t as a Bridge to Transplant
Figure 4‑163: AMPLATZER PFO Occluder Post Approval Study
Figure 4‑164: GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Figure 4‑165: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Figure 4‑166: Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale
Figure 4‑167: Amplatzer PFO Occluder Post-marketing Surveillance Study
Figure 4‑168: Internal Microstructure of Patent Foramen Ovale Related to Stroke
Figure 4‑169: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Figure 4‑170: Amplatzer Piccolo Occluder Japan Post-Marketing Database Surveillance
Figure 4‑171: Nit-Occlud PDA Post-Approval Study
Figure 4‑172: Procedural Outcomes of Percutaneous PDA Closure: Comparative Study between Different Devices
Figure 4‑173: A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography
Figure 4‑174: The ICE WATCHMAN Trial
Figure 4‑175: VClip Post-Market Study
Figure 4‑176: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong
Figure 4‑177: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures
Figure 4‑178: CentriMag Failure-to-Wean Post Approval Study
Figure 4‑179: Quality of Life 1y and 2 y After VV-ECMO for COVID-19
Figure 4‑180: ECMO Treatment of Children in China in the Past 10 Years
Figure 4‑181: TandemHeart Experiences and MEthods
Figure 5‑1: Currency Exchange Rate, 2023
Figure 5‑2: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (1 of 3)
Figure 5‑3: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (2 of 3)
Figure 5‑4: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (€M) (3 of 3)
Figure 5‑5: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (1 of 3)
Figure 5‑6: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (2 of 3)
Figure 5‑7: Cardiac Surgery Market by Segment, Europe, 2020 – 2030 (US$M) (3 of 3)
Figure 5‑8: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (1 of 4)
Figure 5‑9: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (2 of 4)
Figure 5‑10: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (3 of 4)
Figure 5‑11: Leading Competitors, Cardiac Surgery Market, Europe, 2023 (4 of 4)
Figure 5‑12: Other Notable Competitors, Cardiac Surgery Market, Europe, 2023
Figure 5‑13: SWOT Analysis, Abbott (1 of 2)
Figure 5‑14: SWOT Analysis, Abbott (2 of 2)
Figure 5‑15: SWOT Analysis, Abiomed
Figure 5‑16: SWOT Analysis, Artivion
Figure 5‑17: SWOT Analysis, AtriCure
Figure 5‑18: SWOT Analysis, B. Braun
Figure 5‑19: SWOT Analysis, Boston Scientific
Figure 5‑20: SWOT Analysis, Edwards Lifesciences
Figure 5‑21: SWOT Analysis, Getinge
Figure 5‑22: SWOT Analysis, LivaNova
Figure 5‑23: SWOT Analysis, Medtronic
Figure 5‑24: SWOT Analysis, Terumo
Figure 7‑1: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (1 of 3)
Figure 7‑2: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (2 of 3)
Figure 7‑3: Total Cardiac Surgery Procedures by Segment, Europe, 2020 – 2030 (3 of 3)
Figure 7‑4: Total Cardiac Surgery Procedures by Country, Europe, 2020 – 2030
Figure 7‑5:  Surgical Heart Valve Replacement Procedures by Type, Europe, 2020 – 2030
Figure 7‑6:  Surgical Heart Valve Replacement Procedures by Country, Europe, 2020 – 2030
Figure 7‑7: Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑8: Tissue Heart Valve Procedures by Valve Type, Europe, 2020 – 2030
Figure 7‑9: Aortic Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑10: Mitral Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑11: Tricuspid Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑12: Pulmonary Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑13: Tissue Heart Valve Procedures by Material Type, Europe, 2020 – 2030
Figure 7‑14: Xenograft Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑15: Allograft Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑16: Tissue Heart Valve Procedures by Device Type, Europe, 2020 – 2030
Figure 7‑17: Stented Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑18: Stentless Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑19: Sutureless/Rapid Deployment Tissue Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑20: Mechanical Heart Valve Procedures by Valve Type, Europe, 2020 – 2030
Figure 7‑21: Total Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑22: Aortic Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑23: Mitral Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑24: Tricuspid Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑25: Pulmonary Mechanical Heart Valve Procedures by Country, Europe, 2020 – 2030
Figure 7‑26: Annuloplasty Repair Procedures by Valve Type, Europe, 2020 – 2030
Figure 7‑27: Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030
Figure 7‑28: Mitral Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030
Figure 7‑29: Tricuspid Annuloplasty Repair Procedures by Country, Europe, 2020 – 2030
Figure 7‑30: TMVr Procedures by Country, Europe, 2020 – 2030
Figure 7‑31: TAVR Procedures by Country, Europe, 2020 – 2030
Figure 7‑32: TAVR Procedures by Approach, Europe, 2020 – 2030
Figure 7‑33: Transfemoral TAVR Procedures by Country, Europe, 2020 – 2030
Figure 7‑34: Transapical TAVR Procedures by Country, Europe, 2020 – 2030
Figure 7‑35: Other TAVR Procedures by Country, Europe, 2020 – 2030
Figure 7‑36: TAVR Procedures by Patient Risk Class, Europe, 2023
Figure 7‑37: TAVR Procedures by Embolic Protection, Europe, 2020 – 2030
Figure 7‑38: TAVR Procedures with Cerebral Embolic Protection by Country, Europe, 2020 – 2030
Figure 7‑39: TAVR Procedures without Cerebral Embolic Protection by Country, Europe, 2020 – 2030
Figure 7‑40: TPVR Procedures by Country, Europe, 2020 – 2030
Figure 7‑41: TMV Procedures by Country, Europe, 2020 – 2030
Figure 7‑42: Balloon Valvuloplasty Procedures by Device Type, Europe, 2020 – 2030
Figure 7‑43: Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030
Figure 7‑44: Aortic Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030
Figure 7‑45: Mitral Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030
Figure 7‑46: Pulmonary Balloon Valvuloplasty Procedures by Country, Europe, 2020 – 2030
Figure 7‑47: CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑48: CABG Procedures by Support, Europe, 2020 – 2030
Figure 7‑49: OPCAB CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑50: ONCAB CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑51: MISC/MIDCAB CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑52: CABG Procedures by Support, Europe, 2020 – 2030
Figure 7‑53: Open Vessel Harvesting CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑54: Endoscopic Vessel Harvesting CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑55: CABG Procedures by Support, Europe, 2020 – 2030
Figure 7‑56: Traditional Suture CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑57: Anastomosis Assist Device CABG Procedures by Country, Europe, 2020 – 2030
Figure 7‑58: Autotransfusion Procedures by Type, Europe, 2020 – 2030
Figure 7‑59: Autotransfusion Procedures by Country, Europe, 2020 – 2030
Figure 7‑60: Cardiovascular and Other Autotransfusion Procedures by Country, Europe, 2020 – 2030
Figure 7‑61: Orthopedic Autotransfusion Procedures by Country, Europe, 2020 – 2030
Figure 7‑62: Ventricular Assist Device Procedures by Type, Europe, 2020 – 2030
Figure 7‑63: pVAD Procedures by Heart Side, Europe, 2020 – 2030
Figure 7‑64: Left Heart pVAD Procedures by Country, Europe, 2020 – 2030
Figure 7‑65: Right Heart pVAD Procedures by Country, Europe, 2020 – 2030
Figure 7‑66: Destination Therapy Implantable VAD Procedures by Country, Europe, 2020 – 2030
Figure 7‑67: Bridge-to-Transplant Implantable VAD Procedures by Country, Europe, 2020 – 2030
Figure 7‑68: Bridge-to-Recovery Implantable VAD Procedures by Country, Europe, 2020 – 2030
Figure 7‑69: IABP Procedures by Country, Europe, 2020 – 2030
Figure 7‑70: Artificial Heart Procedures by Country, Europe, 2020 – 2030
Figure 7‑71: PFO Closure Procedures by Country, Europe, 2020 – 2030
Figure 7‑72: PDA Procedures by Country, Europe, 2020 – 2030
Figure 7‑73: Total Septal Defect Procedures by Type, Europe, 2020 – 2030
Figure 7‑74: Septal Defect Closure Procedures by Country, Europe, 2020 – 2030
Figure 7‑75: Atrial Septal Defect Closure Procedures by Country, Europe, 2020 – 2030
Figure 7‑76: Ventricular Septal Defect Closure Procedures by Country, Europe, 2020 – 2030
Figure 7‑77: Left Atrial Appendage Closure Device Procedures by Type, Europe, 2020 – 2030
Figure 7‑78: LAA Closure Device Procedures by Country, Europe, 2020 – 2030
Figure 7‑79: Endocardial Closure Device Procedures by Country, Europe, 2020 – 2030
Figure 7‑80: Epicardial Clip Procedures by Country, Europe, 2020 – 2030
Figure 7‑81: Epicardial Suture Procedures by Country, Europe, 2020 – 2030
Figure 7‑82: TMR Procedures by Country, Europe, 2020 – 2030
Figure 7‑83: ECMO Procedures by Modality, Europe, 2020 – 2030
Figure 7‑84: ECMO Procedures by Country, Europe, 2020 – 2030
Figure 7‑85: VA ECMO Procedures by Country, Europe, 2020 – 2030
Figure 7‑86: VV ECMO Procedures by Country, Europe, 2020 – 2030
Figure 7‑87: AV ECMO Procedures by Country, Europe, 2020 – 2030
Figure 8‑1: Tissue Heart Valve Market by Segment, Europe, 2020 – 2030 (€M)
Figure 8‑2: Tissue Heart Valve Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 8‑3: Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑4: Units Sold by Country, Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑5: Average Selling Price by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (€)
Figure 8‑6: Average Selling Price by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (US$)
Figure 8‑7: Market Value by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (€M)
Figure 8‑8: Market Value by Country, Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M)
Figure 8‑9: Stented Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑10: Units Sold by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑11: Average Selling Price by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (€)
Figure 8‑12: Average Selling Price by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (US$)
Figure 8‑13: Market Value by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (€M)
Figure 8‑14: Market Value by Country, Stented Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M)
Figure 8‑15: Stentless Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑16: Units Sold by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑17: Average Selling Price by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (€)
Figure 8‑18: Average Selling Price by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (US$)
Figure 8‑19: Market Value by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (€M)
Figure 8‑20: Market Value by Country, Stentless Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M)
Figure 8‑21: Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑22: Units Sold by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030
Figure 8‑23: Average Selling Price by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (€)
Figure 8‑24: Average Selling Price by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (US$)
Figure 8‑25: Market Value by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (€M)
Figure 8‑26: Market Value by Country, Sutureless/Rapid Deployment Tissue Heart Valve Market, Europe, 2020 – 2030 (US$M)
Figure 8‑27: Leading Competitors, Tissue Heart Valve Market, Europe, 2023
Figure 9‑1: Mechanical Heart Valve Market, Europe, 2020 – 2030
Figure 9‑2: Units Sold by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030
Figure 9‑3: Average Selling Price by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (€)
Figure 9‑4: Average Selling Price by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (US$)
Figure 9‑5: Market Value by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (€M)
Figure 9‑6: Market Value by Country, Mechanical Heart Valve Market, Europe, 2020 – 2030 (US$M)
Figure 9‑7: Leading Competitors, Mechanical Heart Valve Market, Europe, 2023
Figure 10‑1: Annuloplasty Repair Device Market, Europe, 2020 – 2030
Figure 10‑2: Units Sold by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030
Figure 10‑3: Average Selling Price by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (€)
Figure 10‑4: Average Selling Price by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (US$)
Figure 10‑5: Market Value by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (€M)
Figure 10‑6: Market Value by Country, Annuloplasty Repair Device Market, Europe, 2020 – 2030 (US$M)
Figure 10‑7: Leading Competitors, Annuloplasty Repair Device Market, Europe, 2023
Figure 11‑1: Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030
Figure 11‑2: Units Sold by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030
Figure 11‑3: Average Selling Price by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (€)
Figure 11‑4: Average Selling Price by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (US$)
Figure 11‑5: Market Value by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (€M)
Figure 11‑6: Market Value by Country, Transcatheter Mitral Valve Repair Market, Europe, 2020 – 2030 (US$M)
Figure 11‑7: Leading Competitors, Transcatheter Mitral Valve Repair Market, Europe, 2023
Figure 12‑1: Transcatheter Heart Valve Replacement Market by Segment, Europe, 2020 – 2030 (€M)
Figure 12‑2: Transcatheter Heart Valve Replacement Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 12‑3: Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030
Figure 12‑4: Units Sold by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030
Figure 12‑5: Average Selling Price by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (€)
Figure 12‑6: Average Selling Price by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (US$)
Figure 12‑7: Market Value by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (€M)
Figure 12‑8: Market Value by Country, Transcatheter Heart Valve Replacement Market, Europe, 2020 – 2030 (US$M)
Figure 12‑9: TAVR Market, Europe, 2020 – 2030
Figure 12‑10: Units Sold by Country, TAVR Market, Europe, 2020 – 2030
Figure 12‑11: Average Selling Price by Country, TAVR Market, Europe, 2020 – 2030 (€)
Figure 12‑12: Average Selling Price by Country, TAVR Market, Europe, 2020 – 2030 (US$)
Figure 12‑13: Market Value by Country, TAVR Market, Europe, 2020 – 2030 (€M)
Figure 12‑14: Market Value by Country, TAVR Market, Europe, 2020 – 2030 (US$M)
Figure 12‑15: TPVR Market, Europe, 2020 – 2030
Figure 12‑16: Units Sold by Country, TPVR Market, Europe, 2020 – 2030
Figure 12‑17: Average Selling Price by Country, TPVR Market, Europe, 2020 – 2030 (€)
Figure 12‑18: Average Selling Price by Country, TPVR Market, Europe, 2020 – 2030 (US$)
Figure 12‑19: Market Value by Country, TPVR Market, Europe, 2020 – 2030 (€M)
Figure 12‑20: Market Value by Country, TPVR Market, Europe, 2020 – 2030 (US$M)
Figure 12‑21: TMVR Market, Europe, 2020 – 2030
Figure 12‑22: Units Sold by Country, TMVR Market, Europe, 2020 – 2030
Figure 12‑23: Average Selling Price by Country, TMVR Market, Europe, 2020 – 2030 (€)
Figure 12‑24: Average Selling Price by Country, TMVR Market, Europe, 2020 – 2030 (US$)
Figure 12‑25: Market Value by Country, TMVR Market, Europe, 2020 – 2030 (€M)
Figure 12‑26: Market Value by Country, TMVR Market, Europe, 2020 – 2030 (US$M)
Figure 12‑27: Leading Competitors, Transcatheter Heart Valve Replacement Market, Europe, 2023
Figure 12‑28: Leading Competitors by Country, Transcatheter Aortic Valve Replacement Market, Europe, 2023
Figure 13‑1: Cerebral Embolic Protection Device Market, Europe, 2020 – 2030
Figure 13‑2: Units Sold by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030
Figure 13‑3: Average Selling Price by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (€)
Figure 13‑4: Average Selling Price by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (US$)
Figure 13‑5: Market Value by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (€M)
Figure 13‑6: Market Value by Country, Cerebral Embolic Protection Device Market, Europe, 2020 – 2030 (US$M)
Figure 13‑7: Leading Competitors by Country, Cerebral Embolic Protection Device Market, Europe, 2023
Figure 14‑1: Balloon Valvuloplasty Market by Segment, Europe, 2020 – 2030 (€M)
Figure 14‑2: Balloon Valvuloplasty Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 14‑3: Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑4: Units Sold by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑5: Average Selling Price by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€)
Figure 14‑6: Average Selling Price by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$)
Figure 14‑7: Market Value by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M)
Figure 14‑8: Market Value by Country, Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M)
Figure 14‑9: Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑10: Units Sold by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑11: Average Selling Price by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€)
Figure 14‑12: Average Selling Price by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$)
Figure 14‑13: Market Value by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M)
Figure 14‑14: Market Value by Country, Aortic Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M)
Figure 14‑15: Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑16: Units Sold by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑17: Average Selling Price by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€)
Figure 14‑18: Average Selling Price by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$)
Figure 14‑19: Market Value by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M)
Figure 14‑20: Market Value by Country, Mitral Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M)
Figure 14‑21: Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑22: Units Sold by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030
Figure 14‑23: Average Selling Price by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€)
Figure 14‑24: Average Selling Price by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$)
Figure 14‑25: Market Value by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (€M)
Figure 14‑26: Market Value by Country, Pulmonary Balloon Valvuloplasty Market, Europe, 2020 – 2030 (US$M)
Figure 14‑27: Leading Competitors, Balloon Valvuloplasty Market, Europe, 2023
Figure 15‑1: ONCAB Market by Segment, Europe, 2020 – 2030 (€M)
Figure 15‑2: ONCAB Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 15‑3: ONCAB Disposables Market, Europe, 2020 – 2030
Figure 15‑4: Units Sold by Country, ONCAB Disposables Market, Europe, 2020 – 2030
Figure 15‑5: Average Selling Price by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (€)
Figure 15‑6: Average Selling Price by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (US$)
Figure 15‑7: Market Value by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (€M)
Figure 15‑8: Market Value by Country, ONCAB Disposables Market, Europe, 2020 – 2030 (US$M)
Figure 15‑9: Perfusion System Market, Europe, 2020 – 2030
Figure 15‑10: Units Sold by Country, Perfusion System Market, Europe, 2020 – 2030
Figure 15‑11: Average Selling Price by Country, Perfusion System Market, Europe, 2020 – 2030 (€)
Figure 15‑12: Average Selling Price by Country, Perfusion System Market, Europe, 2020 – 2030 (US$)
Figure 15‑13: Market Value by Country, Perfusion System Market, Europe, 2020 – 2030 (€M)
Figure 15‑14: Market Value by Country, Perfusion System Market, Europe, 2020 – 2030 (US$M)
Figure 15‑15: Leading Competitors, ONCAB Market, Europe, 2023
Figure 16‑1: OPCAB Market by Segment, Europe, 2020 – 2030 (€M)
Figure 16‑2: OPCAB Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 16‑3: OPCAB Market, Europe, 2020 – 2030
Figure 16‑4: Units Sold by Country, OPCAB Market, Europe, 2020 – 2030
Figure 16‑5: Average Selling Price by Country, OPCAB Market, Europe, 2020 – 2030 (€)
Figure 16‑6: Average Selling Price by Country, OPCAB Market, Europe, 2020 – 2030 (US$)
Figure 16‑7: Market Value by Country, OPCAB Market, Europe, 2020 – 2030 (€M)
Figure 16‑8: Market Value by Country, OPCAB Market, Europe, 2020 – 2030 (US$M)
Figure 16‑9: Stabilizer Device Market, Europe, 2020 – 2030
Figure 16‑10: Units Sold by Country, Stabilizer Device Market, Europe, 2020 – 2030
Figure 16‑11: Average Selling Price by Country, Stabilizer Device Market, Europe, 2020 – 2030 (€)
Figure 16‑12: Average Selling Price by Country, Stabilizer Device Market, Europe, 2020 – 2030 (US$)
Figure 16‑13: Market Value by Country, Stabilizer Device Market, Europe, 2020 – 2030 (€M)
Figure 16‑14: Market Value by Country, Stabilizer Device Market, Europe, 2020 – 2030 (US$M)
Figure 16‑15: Positioner Market, Europe, 2020 – 2030
Figure 16‑16: Units Sold by Country, Positioner Market, Europe, 2020 – 2030
Figure 16‑17: Average Selling Price by Country, Positioner Market, Europe, 2020 – 2030 (€)
Figure 16‑18: Average Selling Price by Country, Positioner Market, Europe, 2020 – 2030 (US$)
Figure 16‑19: Market Value by Country, Positioner Market, Europe, 2020 – 2030 (€M)
Figure 16‑20: Market Value by Country, Positioner Market, Europe, 2020 – 2030 (US$M)
Figure 16‑21: Leading Competitors, OPCAB Market, Europe, 2023
Figure 17‑1: Autotransfusion Device Market by Segment, Europe, 2020 – 2030 (€M)
Figure 17‑2: Autotransfusion Device Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 17‑3: Autotransfusion Machine Market, Europe, 2020 – 2030
Figure 17‑4: Units Sold by Country, Autotransfusion Machine Market, Europe, 2020 – 2030
Figure 17‑5: Average Selling Price by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (€)
Figure 17‑6: Average Selling Price by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (US$)
Figure 17‑7: Market Value by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (€M)
Figure 17‑8: Market Value by Country, Autotransfusion Machine Market, Europe, 2020 – 2030 (US$M)
Figure 17‑9: Autotransfusion Disposables Market, Europe, 2020 – 2030
Figure 17‑10: Units Sold by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030
Figure 17‑11: Average Selling Price by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (€)
Figure 17‑12: Average Selling Price by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (US$)
Figure 17‑13: Market Value by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (€M)
Figure 17‑14: Market Value by Country, Autotransfusion Disposables Market, Europe, 2020 – 2030 (US$M)
Figure 17‑15: Leading Competitors, Autotransfusion Device Market, Europe, 2023
Figure 18‑1: Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030
Figure 18‑2: Units Sold by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030
Figure 18‑3: Average Selling Price by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (€)
Figure 18‑4: Average Selling Price by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (US$)
Figure 18‑5: Market Value by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (€M)
Figure 18‑6: Market Value by Country, Endoscopic Vessel Harvesting Device Market, Europe, 2020 – 2030 (US$M)
Figure 18‑7: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Europe, 2023
Figure 19‑1: Anastomosis Assist Device Market, Europe, 2020 – 2030
Figure 19‑2: Units Sold by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030
Figure 19‑3: Average Selling Price by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (€)
Figure 19‑4: Average Selling Price by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (US$)
Figure 19‑5: Market Value by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (€M)
Figure 19‑6: Market Value by Country, Anastomosis Assist Device Market, Europe, 2020 – 2030 (US$M)
Figure 19‑7: Leading Competitors, Anastomosis Assist Device Market, Europe, 2023
Figure 20‑1: Transmyocardial Revascularization Device Market by Segment, Europe, 2020 – 2030 (€M)
Figure 20‑2: Transmyocardial Revascularization Device Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 20‑3: Single-Use Fiber-Optic Handpiece Market, Europe, 2020 – 2030
Figure 20‑4: Transmyocardial Revascularization Laser Console Market by Segment, Europe,  2020 – 2030 (€M)
Figure 20‑5: Transmyocardial Revascularization Laser Console Market by Segment, Europe,  2020 – 2030 (US$M)
Figure 20‑6: Leading Competitors, TMR Device Market, Europe, 2023
Figure 21‑1: Ventricular Assist Device Market by Segment, Europe, 2020 – 2030 (€M)
Figure 21‑2: Ventricular Assist Device Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 21‑3: Ventricular Assist Device Market, Europe, 2020 – 2030
Figure 21‑4: Units Sold by Country, Ventricular Assist Device Market, Europe, 2020 – 2030
Figure 21‑5: Average Selling Price by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (€)
Figure 21‑6: Average Selling Price by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (US$)
Figure 21‑7: Market Value by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (€M)
Figure 21‑8: Market Value by Country, Ventricular Assist Device Market, Europe, 2020 – 2030 (US$M)
Figure 21‑9: pVAD Market by Segment, Europe, 2020 – 2030 (€M)
Figure 21‑10: pVAD Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 21‑11: Total pVAD Market, Europe, 2020 – 2030
Figure 21‑12: Units Sold by Country, Total pVAD Market, Europe, 2020 – 2030
Figure 21‑13: Average Selling Price by Country, Total pVAD Market, Europe, 2020 – 2030 (€)
Figure 21‑14: Average Selling Price by Country, Total pVAD Market, Europe, 2020 – 2030 (US$)
Figure 21‑15: Market Value by Country, Total pVAD Market, Europe, 2020 – 2030 (€M)
Figure 21‑16: Market Value by Country, Total pVAD Market, Europe, 2020 – 2030 (US$M)
Figure 21‑17: Left Heart pVAD Market, Europe, 2020 – 2030
Figure 21‑18: Units Sold by Country, Left Heart pVAD Market, Europe, 2020 – 2030
Figure 21‑19: Average Selling Price by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (€)
Figure 21‑20: Average Selling Price by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (US$)
Figure 21‑21: Market Value by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (€M)
Figure 21‑22: Market Value by Country, Left Heart pVAD Market, Europe, 2020 – 2030 (US$M)
Figure 21‑23: Right Heart pVAD Market, Europe, 2020 – 2030
Figure 21‑24: Units Sold by Country, Right Heart pVAD Market, Europe, 2020 – 2030
Figure 21‑25: Average Selling Price by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (€)
Figure 21‑26: Average Selling Price by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (US$)
Figure 21‑27: Market Value by Country, Right Heart pVAD Market, Europe, 2020 – 2030 (€M)
Figure 21‑28: Market Value by Country, Right Heart pVAD Market, Europe, 2020– 2030 (US$M)
Figure 21‑29: Implantable VAD Market, Europe, 2020 – 2030
Figure 21‑30: Units Sold by Country, Implantable VAD Market, Europe, 2020 – 2030
Figure 21‑31: Average Selling Price by Country, Implantable VAD Market, Europe, 2020 – 2030 (€)
Figure 21‑32: Average Selling Price by Country, Implantable VAD Market, Europe, 2020 – 2030 (US$)
Figure 21‑33: Market Value by Country, Implantable VAD Market, Europe, 2020 – 2030 (€M)
Figure 21‑34: Market Value by Country, Implantable VAD Market, Europe, 2020 – 2030 (US$M)
Figure 21‑35: Leading Competitors, Ventricular Assist Device Market, Europe, 2023
Figure 22‑1: Intra-Aortic Balloon Device Market by Segment, Europe, 2020 – 2030 (€M)
Figure 22‑2: Intra-Aortic Balloon Device Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 22‑3: IAB Catheter Market, Europe, 2020 – 2030
Figure 22‑4: Units Sold by Country, IAB Catheter Market, Europe, 2020 – 2030
Figure 22‑5: Average Selling Price by Country, IAB Catheter Market, Europe, 2020 – 2030 (€)
Figure 22‑6: Average Selling Price by Country, IAB Catheter Market, Europe, 2020 – 2030 (US$)
Figure 22‑7: Market Value by Country, IAB Catheter Market, Europe, 2020 – 2030 (€M)
Figure 22‑8: Market Value by Country, IAB Catheter Market, Europe, 2020 – 2030 (US$M)
Figure 22‑9: IABP Console Market, Europe, 2020 – 2030
Figure 22‑10: Units Sold by Country, IABP Console Market, Europe, 2020 – 2030
Figure 22‑11: Installed Base by Country, IABP Console Market, Europe, 2020 – 2030
Figure 22‑12: Average Selling Price by Country, IABP Console Market, Europe, 2020 – 2030 (€)
Figure 22‑13: Average Selling Price by Country, IABP Console Market, Europe, 2020 – 2030 (US$)
Figure 22‑14: Market Value by Country, IABP Console Market, Europe, 2020 – 2030 (€M)
Figure 22‑15: Market Value by Country, IABP Console Market, Europe, 2020 – 2030 (US$M)
Figure 22‑16: Leading Competitors, Intra-Aortic Balloon Device Market, Europe, 2023
Figure 23‑1: Artificial Heart Device Market, Europe, 2020 – 2030
Figure 23‑2: Units Sold by Country, Artificial Heart Device Market, Europe, 2020 – 2030
Figure 23‑3: Average Selling Price by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (€)
Figure 23‑4: Average Selling Price by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (US$)
Figure 23‑5: Market Value by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (€M)
Figure 23‑6: Market Value by Country, Artificial Heart Device Market, Europe, 2020 – 2030 (US$M)
Figure 23‑7: Leading Competitors, Artificial Heart Device Market, Europe, 2023
Figure 24‑1: Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030
Figure 24‑2: Units Sold by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030
Figure 24‑3: Average Selling Price by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (€)
Figure 24‑4: Average Selling Price by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 24‑5: Market Value by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 24‑6: Market Value by Country, Patent Foramen Ovale Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 24‑7: Leading Competitors, Patent Foramen Ovale Closure Device Market, Europe, 2023
Figure 25‑1: Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030
Figure 25‑2: Units Sold by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030
Figure 25‑3: Average Selling Price by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (€)
Figure 25‑4: Average Selling Price by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 25‑5: Market Value by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 25‑6: Market Value by Country, Patent Ductus Arteriosus Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 25‑7: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, Europe, 2023
Figure 26‑1: Atrial & Ventricular Septal Defect Closure Device Market by Segment,  Europe, 2020 – 2030 (€M)
Figure 26‑2: Atrial & Ventricular Septal Defect Closure Device Market by Segment,  Europe, 2020 – 2030 (US$M)
Figure 26‑3: Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑4: Units Sold by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑5: Average Selling Price by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€)
Figure 26‑6: Average Selling Price by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 26‑7: Market Value by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 26‑8: Market Value by Country, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 26‑9: Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑10: Units Sold by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑11: Average Selling Price by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (€)
Figure 26‑12: Average Selling Price by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 26‑13: Market Value by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 26‑14: Market Value by Country, Atrial Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 26‑15: Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑16: Units Sold by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030
Figure 26‑17: Average Selling Price by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€)
Figure 26‑18: Average Selling Price by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 26‑19: Market Value by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 26‑20: Market Value by Country, Ventricular Septal Defect Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 26‑21: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Europe, 2023
Figure 27‑1: Left Atrial Appendage Closure Device Market by Segment, Europe, 2020 – 2030 (€M)
Figure 27‑2: Left Atrial Appendage Closure Device Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 27‑3: Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030
Figure 27‑4: Units Sold by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030
Figure 27‑5: Average Selling Price by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (€)
Figure 27‑6: Average Selling Price by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (US$)
Figure 27‑7: Market Value by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (€M)
Figure 27‑8: Market Value by Country, Left Atrial Appendage Closure Device Market, Europe, 2020 – 2030 (US$M)
Figure 27‑9: Endocardial Market, Europe, 2020 – 2030
Figure 27‑10: Units Sold by Country, Endocardial Market, Europe, 2020 – 2030
Figure 27‑11: Average Selling Price by Country, Endocardial Market, Europe, 2020 – 2030 (€)
Figure 27‑12: Average Selling Price by Country, Endocardial Market, Europe, 2020 – 2030 (US$)
Figure 27‑13: Market Value by Country, Endocardial Market, Europe, 2020 – 2030 (€M)
Figure 27‑14: Market Value by Country, Endocardial Market, Europe, 2020 – 2030 (US$M)
Figure 27‑15: Epicardial Clip Market, Europe, 2020 – 2030
Figure 27‑16: Units Sold by Country, Epicardial Clip Market, Europe, 2020 – 2030
Figure 27‑17: Average Selling Price by Country, Epicardial Clip Market, Europe, 2020 – 2030 (€)
Figure 27‑18: Average Selling Price by Country, Epicardial Clip Market, Europe, 2020 – 2030 (US$)
Figure 27‑19: Market Value by Country, Epicardial Clip Market, Europe, 2020 – 2030 (€M)
Figure 27‑20: Market Value by Country, Epicardial Clip Market, Europe, 2020 – 2030 (US$M)
Figure 27‑21: Epicardial Suture Market, Europe, 2020 – 2030
Figure 27‑22: Units Sold by Country, Epicardial Suture Market, Europe, 2020 – 2030
Figure 27‑23: Average Selling Price by Country, Epicardial Suture Market, Europe, 2020 – 2030 (€)
Figure 27‑24: Average Selling Price by Country, Epicardial Suture Market, Europe, 2020 – 2030 (US$)
Figure 27‑25: Market Value by Country, Epicardial Suture Market, Europe, 2020 – 2030 (€M)
Figure 27‑26: Market Value by Country, Epicardial Suture Market, Europe, 2020 – 2030 (US$M)
Figure 27‑27: Leading Competitors, Left Atrial Appendage Closure Device Market, Europe, 2023
Figure 28‑1: Preshaped Guidewire Market, Europe, 2020 – 2030
Figure 28‑2: Units Sold by Country, Preshaped Guidewire Market, Europe, 2020 – 2030
Figure 28‑3: Average Selling Price by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (€)
Figure 28‑4: Average Selling Price by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (US$)
Figure 28‑5: Market Value by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (€M)
Figure 28‑6: Market Value by Country, Preshaped Guidewire Market, Europe, 2020 – 2030 (US$M)
Figure 28‑7: Leading Competitors, Preshaped Guidewire Market, Europe, 2023
Figure 29‑1: ECMO Market by Segment, Europe, 2020 – 2030 (€M)
Figure 29‑2: ECMO Market by Segment, Europe, 2020 – 2030 (US$M)
Figure 29‑3: ECMO Disposables Market, Europe, 2020 – 2030
Figure 29‑4: Units Sold by Country, ECMO Disposables Market, Europe, 2020 – 2030
Figure 29‑5: Average Selling Price by Country, ECMO Disposables Market, Europe, 2020 – 2030 (€)
Figure 29‑6: Average Selling Price by Country, ECMO Disposables Market, Europe, 2020 – 2030 (US$)
Figure 29‑7: Market Value by Country, ECMO Disposables Market, Europe, 2020 – 2030 (€M)
Figure 29‑8: Market Value by Country, ECMO Disposables Market, Europe, 2020 – 2030 (US$M)
Figure 29‑9: ECMO Machine Market, Europe, 2020 – 2030
Figure 29‑10: Units Sold by Country, ECMO Machine Market, Europe, 2020 – 2030
Figure 29‑11: Average Selling Price by Country, ECMO Machine Market, Europe, 2020 – 2030 (€)
Figure 29‑12: Average Selling Price by Country, ECMO Machine Market, Europe, 2020 – 2030 (US$)
Figure 29‑13: Market Value by Country, ECMO Machine Market, Europe, 2020 – 2030 (€M)
Figure 29‑14: Market Value by Country, ECMO Machine Market, Europe, 2020 – 2030 (US$M)
Figure 29‑15: Leading Competitors, ECMO Market, Europe, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the European cardiac surgery market was valued at €2.9 billion in 2023. This is expected to increase over the forecast period at a CAGR of 3.4% to reach nearly €3.7 billion.

  • 2024
  • 10 Years
  • Europe
  • 01/04/2024
  • 784
  • MedSuite
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library